Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) using Tricyclic Antidepressants (TCAs)

Introduction to TCAs in IBS-C

  • The American Gastroenterological Association recommends the use of tricyclic antidepressants (TCAs) as second-line therapy for IBS-C, specifically secondary amines such as nortriptyline or desipramine, due to their lower anticholinergic effects 1, 4

Efficacy of TCAs in IBS-C

  • TCAs demonstrate efficacy for global symptom relief (RR 0.67; 95% CI 0.54-0.82) and abdominal pain reduction (RR 0.76-0.94) in patients with IBS-C 2, 3
  • TCAs ranked first among all treatments for IBS pain across all subtypes in network meta-analysis 4

Dosing and Administration of TCAs

  • The recommended dosing protocol for TCAs in IBS-C is to start low and titrate slowly, beginning at 10 mg at bedtime and increasing by 10 mg weekly or every 2 weeks based on response and tolerability 1, 4
  • The target dose is 30-50 mg at bedtime, with a maximum dose of 100 mg/day to minimize cardiovascular risks 1, 4

Important Clinical Considerations

  • The American College of Gastroenterology suggests obtaining an ECG before initiating TCAs in patients over 40 years or with cardiac risk factors, as TCAs can cause QTc prolongation, arrhythmias, and conduction delays 1
  • TCAs are potentially inappropriate for elderly patients (≥65 years) due to strong anticholinergic effects, and alternative neuromodulators should be considered 1

Alternative Therapies

  • If secondary amine TCAs are ineffective or poorly tolerated, alternative neuromodulators such as SNRIs (duloxetine) or mirtazapine can be considered, starting at 30 mg daily and 15 mg daily, respectively, and titrating to 60 mg daily and 45 mg daily 4
  • The American Gastroenterological Association suggests avoiding SSRIs for IBS pain due to their minimal analgesic effect 6, 4